We are live on ! Find out more
ACET icon

Adicet Bio
ACET

44 hedge funds and large institutions have $134M invested in Adicet Bio in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 2

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

38% more funds holding

Funds holding: 32 → 44 (+12)

25% more capital invested

Capital invested by funds: $108M → $134M (+$26.4M)

0.1% more ownership

Funds ownership: 2.93% → 3.04% (+0.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
44
Holders Change
+12
Holders Change %
+37.5%
% of All Funds
0.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
12
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$3.46M
2
BlackRock
BlackRock
New York
+$1.8M
3
JGC
J. Goldman & Co
New York
+$1.3M
4
ECM
ExodusPoint Capital Management
New York
+$607K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$485K

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$1.28M
2
NCM
Nantahala Capital Management
Connecticut
-$911K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$797K
4
AC
AWH Capital
Texas
-$357K
5
EWM
Edge Wealth Management
New York
-$156K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$94.3M – – –
JJIJ
2
Johnson & Johnson Innovation - JJDC
New Jersey
$9.31M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$5.12M +$3.46M +16,896 +288%
NCM
4
Nantahala Capital Management
Connecticut
$4.83M -$911K -4,448 -17%
BlackRock
5
BlackRock
New York
$3.86M +$1.8M +8,775 +105%
Baillie Gifford & Co
6
Baillie Gifford & Co
United Kingdom
$2.55M – – –
IC
7
Ikarian Capital
Texas
$2.45M -$1.28M -6,250 -36%
AG
8
Artal Group
Luxembourg
$1.82M – – –
JGC
9
J. Goldman & Co
New York
$1.42M +$1.3M +6,328 New
DCM
10
DAFNA Capital Management
California
$1.09M +$128K +625 +15%
ECM
11
ExodusPoint Capital Management
New York
$666K +$607K +2,964 New
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$632K -$797K -3,890 -58%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$602K +$130K +637 +31%
Qube Research & Technologies (QRT)
14
Qube Research & Technologies (QRT)
United Kingdom
$533K +$485K +2,370 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$470K +$59.6K +291 +16%
Two Sigma Advisers
16
Two Sigma Advisers
New York
$421K -$135K -661 -26%
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$386K – – –
Two Sigma Investments
18
Two Sigma Investments
New York
$382K +$218K +1,062 +166%
6CM
19
683 Capital Management
New York
$362K +$330K +1,609 New
BFM
20
Boothbay Fund Management
New York
$355K +$7.58K +37 +2%
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$351K +$320K +1,562 New
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$344K +$156K +764 +99%
BCM
23
Bridgeway Capital Management
Texas
$341K – – –
Millennium Management
24
Millennium Management
New York
$310K +$283K +1,380 New
Morgan Stanley
25
Morgan Stanley
New York
$222K +$78.4K +383 +63%
1
2

ACET Hedge Fund Activity: Q4 2020 in Review

44 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q4 2020, worth a combined $134M — up 25% from $108M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ACET positions and 2 closed out — a net gain of 12 holders — while 12 added to existing stakes and 8 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.46M. The largest seller was Ikarian Capital, cutting an estimated $1.28M.

  • 44 institutional investors held Adicet Bio (ACET) as of Q4 2020, up from 32 in Q3 2020.
  • Funds reported $134M of Adicet Bio stock for Q4 2020, up 25% quarter-over-quarter.
  • 14 funds opened new Adicet Bio positions in Q4 2020 and 2 closed out, a net change of +12 holders.
  • The largest Adicet Bio buyer in Q4 2020 was Vanguard Group, an estimated $3.46M added.
  • The largest Adicet Bio seller in Q4 2020 was Ikarian Capital, an estimated $1.28M sold.

Based on aggregated 13F filings for Q4 2020.